Scotiabank analyst Greg Harrison raised the firm’s price target on BridgeBio (BBIO) to $49 from $48 and keeps an Outperform rating on the shares. BridgeBio recently announced its European partner ...

AB-1002 is an investigational gene therapy for the treatment of adults with non-ischemic cardiomyopathy and New York Heart Association (NYHA) ...

If a language can be used to build web scrapers, it definitely needs to provide a graceful data visualization library. --- by dongdong. In the Golang ecosystem, there are not many choices for data ...

Bristol-Myers Squibb's Cobenfy launch shows strong initial sales and growth potential. Learn why BMY stock is a solid ...

The United States market has shown robust performance recently, climbing 3.0% in the last week and achieving a 25% increase over the past year, with earnings expected to grow by 15% annually.

Dr. Kilaru has has worked on more claims relating to Atrial Flutter, Arrhythmias and Cardiomyopathy than other providers in the area. At present, Dr. Kilaru has received an average rating of 4.5 ...

The decrease in mortality, morbidity were seen with trametinib for children with RASopathy-associated hypertrophic cardiomyopathy. HealthDay News — For children with severe hypertrophic cardiomyopathy ...

The United States (US) Food and Drug Administration (FDA) approved mavacamten for the treatment of obstructive hypertrophic cardiomyopathy (HCM) in 2022. However, due to left ventricular (LV) systolic ...

Though metrics such as GDP and job growth show a healthy economy, these seven charts offer insight into why Americans are still feeling crunched. Inflation has cooled significantly since its red ...

Kiss surges to No. 2 on Billboard's Hard Rock Digital Song Sales chart as “I Was Made For Lovin’ ... [+] You” matches the band's all-time peak on the ranking. Gene Simmons, Ace Frehley ...